Invus Public Equities, L.P.

Insider Buys Quantity –
43
2023-10-12PurchaseScholar Rock Holding Corporation
SRRK
10 percent owner
2.2M
3.3287%
$6.86$15.09M+80.4%
2023-04-28PurchaseScholar Rock Holding Corporation
SRRK
10 percent owner
31,557
0.0398%
$6.43$202,845+57.27%
2023-02-24PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
100,000
0.1667%
$1.70$170,000-5.33%
2023-02-23PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
200,000
0.3399%
$1.75$350,760-6.14%
2023-02-22PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
150,000
0.2504%
$1.79$268,995-9.83%
2023-02-21PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
50,000
0.0798%
$1.85$92,500-16.41%
2023-02-17PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
200,000
0.3006%
$1.71$341,000-14.89%
2023-02-16PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
315,266
0.4849%
$1.68$531,129-11.81%
2023-02-15PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
1M
2.3501%
$2.16$2.16M+5.59%
2023-02-09PurchaseGlycoMimetics, Inc.
GLYC
10 percent owner
11,451
0.0189%
$3.24$37,123-50.92%
2023-01-09SaleScholar Rock Holding Corporation
SRRK
director
1,094
0.0014%
$9.48$10,373-15.33%
2023-01-05PurchaseScholar Rock Holding Corporation
SRRK
director
48,774
0.0608%
$9.33$455,091-14.52%
2022-10-25PurchaseScholar Rock Holding Corporation
SRRK
director
130,265
0.2169%
$8.04$1.05M-3.64%
2021-08-03PurchaseOmega Therapeutics, Inc.
OMGA
10 percent owner
875,000
2.7992%
$17.00$14.88M-32.01%
2021-07-30PurchaseOmega Therapeutics, Inc.
OMGA
10 percent owner
75,000
0.2342%
$16.14$1.21M-29.19%
2021-02-01SaleSeer, Inc.
SEER
10 percent owner
505,090
0.8995%
$64.15$32.4M-44.79%
2020-12-16PurchaseLexicon Pharmaceuticals, Inc.
LXRX
10.94M
9.4404%
$3.20$35M+59.57%
2020-12-08PurchaseSeer, Inc.
SEER
10 percent owner
1.58M
2.0239%
$19.00$30.02M-41.24%
2020-06-16PurchaseGeneration Bio Co.
GBIO
10 percent owner
1.6M
12.8154%
$19.00$30.4M+47.36%
2018-06-28PurchaseLexicon Pharmaceuticals, Inc.
LXRX
115,448
0.1066%
$12.45$1.44M-42.31%